治疗癌症疫苗开发的挑战和新方向
Danjie Pan1,2, Jiayang Liu2, Xuan Huang2
1Laboratory of Drug Discovery from Natural Resources and Industrialization, School of Pharmacy, Macau University of Science and Technology, Macau 999078, China.
治疗性瘤疫苗对固体瘤有希望,但面临着免疫抑制等挑战. 在现场匿名抗原疫苗为有效的癌症免疫疗法和记忆发展提供了新的方向.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 疫苗学 疫苗学 疫苗学
背景情况:
- 治疗性瘤疫苗是固体瘤的有希望的免疫治疗策略.
- 关键目标包括诱导瘤回归,建立长期抗瘤记忆,并最大限度地减少不良影响.
- 瘤诱导的免疫抑制和耐药性对疫苗有效性构成重大障碍.
研究的目的:
- 审查开发治疗性瘤疫苗的挑战.
- 突出匿名抗原疫苗在现场作为一种新的方法.
- 为未来的瘤疫苗研究提供参考.
主要方法:
- 关于治疗瘤疫苗开发当前挑战的文献综述.
- 专注于在现场注射的匿名抗原疫苗.
- 在这个新兴领域的研究进展的总结.
主要成果:
- 确定了治疗瘤疫苗开发的关键障碍,包括免疫逃避机制.
- 探索了在现场匿名抗原疫苗的潜力,作为一个有前途的战略.
- 综合了有关新型疫苗方法的当前研究成果.
结论:
- 克服瘤诱导的免疫抑制对于有效的治疗瘤疫苗至关重要.
- 在现场匿名抗原疫苗代表了癌症免疫治疗的潜在开创性方向.
- 需要进一步的研究才能充分发挥这些先进的疫苗策略的潜力.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
相关概念视频
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microorganisms in Medicine and Therapeutics
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
